Richard Chin

Home/Full Member, Members/Richard Chin

Project Description

Richard Chin

Location: San Francisco Bay Area

Member Since: 2014

Membership Type: Full

Richard Chin

Founder and CEO
KindredBio

Richard Chin is the Founder and CEO of KindredBio (NASDAQ:KIN), a biotechnology company that develops medicines for pets.

Richard is a Harvard-trained physician, an Oxford-trained lawyer, and a Rhodes Scholar. He was named by BusinessWeek in 2006 as one of 99 youngest public company CEOs in the United States.

Previously, Richard was Head of Clinical Research for the Biotherapeutics Unit at Genentech where he oversaw half of Genentech’s drug development programs; Senior Vice President of Global Development at Elan; CEO of Oxigene, a NASDAQ-listed biotechnology company; and CEO of OneWorld Health, a Gates Foundation-funded nonprofit developing drugs for impoverished patients in developing countries. Drugs Richard developed have current aggregate sales of well over $10 billion per year.

Richard has authored several major textbooks on clinical development and is on faculty at UCSF. He also serves as a director on multiple corporate boards. His blog can be found at clinicaltrialist.com.

Sign up for our CKA Newsletter

Get news and updates from CKA delivered to your inbox!

  • This field is for validation purposes and should be left unchanged.

By submitting this form, you are granting Council of Korean Americans permission to email you. You can revoke permission to mail to your email address at any time using the SafeUnsubscribe SafeUnsubscribe® link, found at the bottom of every email. We take your privacy seriously (to see for yourself, please read our Email Privacy Policy). Emails are serviced by Constant Contact.

close-link